CARDOZA GEORGE 4
4 · NEOGENOMICS INC · Filed Mar 3, 2020
Insider Transaction Report
Form 4
CARDOZA GEORGE
Chief Financial Officer
Transactions
- Award
Common Stock
2020-03-02$28.33/sh+48,768$1,381,597→ 48,768 totalExercise: $28.33From: 2021-03-02Exp: 2027-03-02→ Common Stock (48,768 underlying) - Award
Common Stock
2020-03-02+7,571→ 333,402 total
Holdings
- 200,000
Stock Option (Right to Buy)
Exercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (200,000 underlying) - 20,000(indirect: By Trust)
Common Stock
- 100,000
Stock Option (Right to Buy)
Exercise: $7.15From: 2017-04-20Exp: 2021-04-20→ Common Stock (100,000 underlying) - 192,500
Stock Options (Right to Buy)
Exercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (192,500 underlying) - 51,459
Stock Option (Right to Buy)
Exercise: $19.60From: 2020-03-01Exp: 2024-03-01→ Common Stock (51,459 underlying)
Footnotes (5)
- [F1]On April 20, 2016, Mr. Cardoza was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F2]On April 28, 2017, Mr. Cardoza was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F3]On February 26, 2018, Mr. Cardoza was granted 192,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F4]On March 1, 2019, Mr. Cardoza was granted 51,459 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2020, Mr. Cardoza was granted 48,768 stock options. These options vest ratably over the first four anniversary dates of the grant date.